166 related articles for article (PubMed ID: 27599111)
1. Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
Selinger CI; Li BT; Pavlakis N; Links M; Gill AJ; Lee A; Clarke S; Tran TN; Lum T; Yip PY; Horvath L; Yu B; Kohonen-Corish MR; O'Toole SA; Cooper WA
Histopathology; 2017 Feb; 70(3):402-411. PubMed ID: 27599111
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Different
Dülger O; Öz B
Balkan Med J; 2023 Sep; 40(5):344-350. PubMed ID: 37318131
[TBL] [Abstract][Full Text] [Related]
3. Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls.
Nambirajan A; Sood R; Khatoon W; Malik PS; Mohan A; Jain D
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38054562
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.
Ilie MI; Bence C; Hofman V; Long-Mira E; Butori C; Bouhlel L; Lalvée S; Mouroux J; Poudenx M; Otto J; Marquette CH; Hofman P
Ann Oncol; 2015 Jan; 26(1):238-244. PubMed ID: 25344360
[TBL] [Abstract][Full Text] [Related]
5. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
Diks J; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA; Medeiros LJ; Tang G; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2024 Jan; 132(1):41-49. PubMed ID: 37747438
[TBL] [Abstract][Full Text] [Related]
6. Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System.
Makarem M; Ezeife DA; Smith AC; Li JJN; Law JH; Tsao MS; Leighl NB
Curr Oncol; 2021 Aug; 28(5):3268-3279. PubMed ID: 34449580
[No Abstract] [Full Text] [Related]
7. Incidence of
Mehta A; Saifi M; Batra U; Suryavanshi M; Gupta K
Lung Cancer (Auckl); 2020; 11():19-25. PubMed ID: 32158297
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of an RNA extraction-free test for the multiplexed detection of
Damiola F; Alberti L; Mansuet-Lupo A; Damotte D; Hofman V; Tixier L; Penault-Llorca F; Rouquette I; Vignaud JM; Cazes A; Forest F; Begueret H; Gibault L; Badoual C; Cayre A; Taranchon-Clermont E; Duc A; Mc Leer A; Lantuejoul S
Expert Rev Mol Diagn; 2023; 23(12):1283-1291. PubMed ID: 37906110
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and diagnostic approach of ROS1 rearrangement in non-small cell lung cancer: a meta-analysis: ROS1 in non-small cell lung cancer.
Yang J; Pyo JS; Kang G
Int J Biol Markers; 2018 Jun; ():1724600818772194. PubMed ID: 29874982
[TBL] [Abstract][Full Text] [Related]
10. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
Dong J; Zhang RY; Sun N; Smalley M; Wu Z; Zhou A; Chou SJ; Jan YJ; Yang P; Bao L; Qi D; Tang X; Tseng P; Hua Y; Xu D; Kao R; Meng M; Zheng X; Liu Y; Vagner T; Chai X; Zhou D; Li M; Chiou SH; Zheng G; Di Vizio D; Agopian VG; Posadas E; Jonas SJ; Ju SP; Weiss PS; Zhao M; Tseng HR; Zhu Y
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13973-13983. PubMed ID: 30892008
[TBL] [Abstract][Full Text] [Related]
11. Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives.
Rossi G; Jocollé G; Conti A; Tiseo M; Zito Marino F; Donati G; Franco R; Bono F; Barbisan F; Facchinetti F
Lung Cancer (Auckl); 2017; 8():45-55. PubMed ID: 28740441
[No Abstract] [Full Text] [Related]
12. Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells.
Dong J; Jan YJ; Cheng J; Zhang RY; Meng M; Smalley M; Chen PJ; Tang X; Tseng P; Bao L; Huang TY; Zhou D; Liu Y; Chai X; Zhang H; Zhou A; Agopian VG; Posadas EM; Shyue JJ; Jonas SJ; Weiss PS; Li M; Zheng G; Yu HH; Zhao M; Tseng HR; Zhu Y
Sci Adv; 2019 Jul; 5(7):eaav9186. PubMed ID: 31392269
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.
Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):570-587. PubMed ID: 29114473
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements.
Zhang X; Li L; Gao F; Liu B; Li J; Ren S; Peng S; Qiu W; Pu X; Ye Q
Diagn Pathol; 2024 Jan; 19(1):1. PubMed ID: 38173003
[TBL] [Abstract][Full Text] [Related]
15. Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies.
Chang X; Liu Z; Man S; Roys A; Li Z; Zuo D; Wu Y
RSC Adv; 2019 Jun; 9(31):17921-17932. PubMed ID: 35520562
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with
Bi H; Ren D; Ding X; Yin X; Cui S; Guo C; Wang H
Transl Cancer Res; 2020 Jul; 9(7):4383-4392. PubMed ID: 35117804
[TBL] [Abstract][Full Text] [Related]
17. ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young Male.
Sahay A; Kumar R; Janu A; Prabhash K
Turk Patoloji Derg; 2020; 1(1):71-77. PubMed ID: 32149365
[TBL] [Abstract][Full Text] [Related]
18. Progress of non-small-cell lung cancer with
Yang X; Tang Z; Li J; Jiang J; Liu Y
Front Mol Biosci; 2023; 10():1238093. PubMed ID: 38187090
[No Abstract] [Full Text] [Related]
19. Diagnostic patterns of non-small-cell lung cancer at Princess Margaret Cancer Centre.
Nadjafi M; Sung MR; Santos GDC; Le LW; Hwang DM; Tsao MS; Leighl NB
Curr Oncol; 2020 Oct; 27(5):244-249. PubMed ID: 33173375
[TBL] [Abstract][Full Text] [Related]
20. Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011-2021.
Yan JT; Jin Y; Lo E; Chen Y; Hanlon Newell AE; Kong Y; Inge LJ
Oncol Ther; 2023 Sep; 11(3):343-360. PubMed ID: 37330972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
